Trade PVLA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Palvella Therapeutics, Inc. (PVLA) is trading at US$126.33, down 3.27% today as of Oct 8, 11:44 EDT. The company has a market capitalisation of US$2.05B. Over the past 52 weeks, PVLA has traded between US$65.93 and US$161.38. On Syfe you can trade PVLA with $0 commission and add it to your watchlist.
| Previous close | US$130.59 |
|---|---|
| Market cap | US$2.05B |
| 52-week range | US$65.93 – US$161.38 |
| Volume | 148.94K |
| Exchange | US |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.
Year: 2024
Palvella Therapeutics Completes Rolling Submission of NDA for QTORIN Rapamycin
Aug 31, 12:08 PM · MT Newswires
Palvella Therapeutics Q2 Net Loss Widens
Aug 4, 1:36 PM · MT Newswires
--Earnings Flash (PVLA) Palvella Therapeutics Posts Q2 Net Loss $1.52 a Share, vs. FactSet Est of $1.07 Loss
Aug 4, 11:39 AM · MT Newswires
Palvella Therapeutics' Qtorin Granted FDA Rolling Review; Shares Rise Pre-Bell
Jun 22, 12:26 PM · MT Newswires
Palvella Therapeutics, Inc. (PVLA) stock is trading at US$126.33, -3.27% from the previous close of US$130.59.
The market cap for Palvella Therapeutics, Inc. (PVLA) stock is approximately US$2.05B.
The 52-week high for Palvella Therapeutics, Inc. (PVLA) stock is US$161.38.
The 52-week low for Palvella Therapeutics, Inc. (PVLA) stock is US$65.93.
Palvella Therapeutics, Inc. (PVLA) does not currently pay a dividend.
Stay on top of PVLA
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
